Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, New York.
Obstet Gynecol. 2020 Apr;135(4):808-811. doi: 10.1097/AOG.0000000000003706.
Recommendations for screening for hepatitis B immunity in pregnancy and vaccinating susceptible women vary among professional societies. The American College of Obstetricians and Gynecologists recommends vaccinating high-risk women for hepatitis B. However, only one fourth of U.S. adults have received a complete hepatitis B vaccination series. Because two thirds of individuals with chronic hepatitis B are unaware of their diagnosis, risk-based screening for immunity followed by vaccination of susceptible women may not identify and protect all women at risk. Acquisition of hepatitis B poses short-term and long-term risks to maternal and fetal health, an outcome that can be prevented by vaccination. Hepatitis B vaccination in pregnancy is safe and efficacious and can be completed during the course of prenatal care. Universal screening for hepatitis B immunity and vaccination of susceptible women in pregnancy should be a priority during prenatal care. Cost-effectiveness studies are needed to validate this approach.
推荐在孕期筛查乙型肝炎免疫并为易感妇女接种疫苗的建议因专业协会而异。美国妇产科医师学会建议为乙型肝炎高危妇女接种疫苗。然而,只有四分之一的美国成年人完成了乙型肝炎疫苗的全程接种系列。由于三分之二的慢性乙型肝炎患者不知道自己的诊断,因此基于风险的免疫筛查,然后为易感妇女接种疫苗,可能无法识别和保护所有处于危险中的妇女。乙型肝炎的获得对母婴健康造成短期和长期风险,这种结局可以通过疫苗接种来预防。妊娠期接种乙型肝炎疫苗是安全有效的,并且可以在产前护理过程中完成。在产前护理期间,应优先考虑对乙型肝炎免疫进行普遍筛查并为易感妇女接种疫苗。需要进行成本效益研究来验证这种方法。